TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pfizer AB
Closing information (x1000 SEK)
| Closing information | 2023/11 | 2022/11 | 2021/11 |
| Turnover |
2,145,521
|
4,188,731
|
670,342 |
| Financial expenses |
1,794
|
3,231
|
120 |
| Earnings before taxes |
117,143
|
44,020
|
28,802 |
| EBITDA |
115,590
|
224,982
|
33,673 |
| Total assets |
1,075,587
|
1,813,396
|
1,496,627 |
| Current assets |
1,046,596
|
1,790,159
|
1,302,044 |
| Current liabilities |
605,971
|
1,434,189
|
1,066,644 |
| Equity capital |
469,616
|
379,207
|
429,983 |
| - share capital |
35,708
|
35,708
|
35,708 |
| Employees (average) |
155
|
145
|
83 |
Financial ratios
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Solvency |
43.7%
|
20.9%
|
28.7% |
| Turnover per employee |
13,842
|
28,888
|
8,076 |
| Profit as a percentage of turnover |
5.5%
|
1.1%
|
4.3% |
| Return on assets (ROA) |
11.1%
|
2.6%
|
1.9% |
| Current ratio |
172.7%
|
124.8%
|
122.1% |
| Return on equity (ROE) |
24.9%
|
11.6%
|
6.7% |
| Change turnover |
-2,043,210
|
3,518,389
|
31,750 |
| Change turnover % |
-49%
|
525%
|
5% |
| Chg. No. of employees |
10
|
62
|
20 |
| Chg. No. of employees % |
7%
|
75%
|
32% |
Total value of public sale
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.